Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Leinco Technologies Inc Anti-Mouse CD44 (Hermes, Pgp1, H-CAM, HUTCH, Ly-24) In Vivo PLATINUM; Clone IM7; Isotype: Rat IgG2b
SDP

Supplier:  Leinco Technologies Inc C236825 MG

Encompass_Preferred

Specificity: IM7 recognizes an epitope common to alloantigens and all isoforms of CD44 that is located between amino acids 145 and 186. Antigen Distribution: CD44 is expressed on all leukocytes, endothelial cells, hepatocytes, and mesenchymal cells in addition to B-cells, monocytes, macrophages and certain subsets of thymocytes and peripheral T-cells. Mice with the Ly-24.1 allotype have high densities of CD44+ T-cells. Background: CD44 is a 80-95 kD glycoprotein. As B and T cells become activated or progress to the memory stage, CD44 expression increases from low/mid levels to high levels. Applications: (IP, WB) IM7 antibody has been shown to neutralize CD44 In vivo. Leinco’s In vivo GOLDTM and In vivo PLATINUMTM functional antibodies are manufactured in an animal free facility using only In vitro cell culture techniques and are purified by a multi-step process including the use of protein A or G to assure extremely low levels of endotoxins, leachable protein A or aggregates.

Catalog No. 50-190-5917


May include imposed supplier surcharges.
Only null left
Add to Cart

Product Content Correction

The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.